Dr. Eddie Méndez was a physician-scientist and cherished colleague at Fred Hutch who died of cancer in 2018 at age 45. An expert in head and neck cancers, Méndez was known for being passionate about ...

I began working at Fred Hutch at the start of 2025, and I split my time between general oncology patients and the palliative care team. At the South Lake Union clinics, I see a wide variety of ...

The Prevention Center shared resource (PCSR) was founded with the goal of facilitating transdisciplinary, collaborative research focused on the prevention and mitigation of disease. Since 2004, over ...

Basic science discoveries underlie the innovative cures and treatments we develop at Fred Hutch. Our research teams strive to understand the normal molecular functioning of cells as well as the ...

At Fred Hutch, we believe that quality of life is essential to building a rewarding career — and achieving our shared mission of advancing breakthroughs and saving lives. It starts with a supportive ...

Save the Date: the Sloan Precision Oncology Institute is hosting a Theranostics Symposium on February 28, 2025. This symposium will feature a panel of local and national leaders in the field who will ...

A novel drug regimen tested for the first time by researchers at Fred Hutch Cancer Center has shown great promise in ...

Phase 2 clinical trial shows a safe dose from a specific donor helped with gut microbiome recovery in people with cancer SEATTLE — Jan. 28, 2025 — A new study shows that oral fecal microbiota ...